Live Patient Surgery to Save an Ailing Dental Implant at the 2016 Greater New York Dental Meeting

Friday, November 18, 2016 Dental News
Email Print This Page Comment bookmark
Font : A-A+

Live demo and educational session showcasing Millennium Dental Technologies' revolutionary LAPIP™ protocol

CERRITOS, Calif., Nov. 17, 2016 /PRNewswire/ -- Millennium Dental Technologies announced its sponsorship of a live demonstration

November 29th at the 2016 Greater New York Dental Meeting (GNYDM) showcasing the LAPIP protocol for failing dental implants.  Dental implants, once considered the permanent replacement for natural teeth, have failure rates of 20-40%. (Lindhe & Meyle 2008, Costa et al 2012) The GNYDM session, "The LAPIP Protocol: A Laser-Mediated Solution for the Ailing and Failing Implant," led by Charles R. Braga, DMD, MMS, will provide attendees with the rare opportunity to watch a live surgery plus learn about the science and benefits of treating peri-implantitis and peri-implant mucositis using the LAPIP protocol.

The LAPIP protocol solves the unique challenges faced in treating ailing and failing dental implants using a less invasive, tissue-saving method preferred by patients. While traditional treatments for failing dental implants include cutting the patient's gums, placement of foreign exogenous growth factors or artificial membranes, then stitching up the site. In contrast, LAPIP treatment helps maintain the integrity of the structural tissue of the gum with positive results - 95% of the failing implants treated with the LAPIP protocol have reintegrated in the pocket and stabilized with bone growth of 3-8 threads. Additionally, it is built upon the foundation of the LANAP protocol, the first and only FDA cleared treatment for True Regeneration™.

Attendees will receive 3 CE credits upon completion of the course. The session will take place on Tuesday, November 29 from 10:00am-12:30pm.

ABOUT MILLENNIUM DENTAL TECHNOLOGIES, INC.: Headquartered in Cerritos, Calif., Millennium Dental Technologies, Inc., is the developer of the LANAP® protocol for the treatment of gum disease and the manufacturer of the PerioLase® MVP-7™ digital dental laser. By providing a simple and comfortable experience with unique bone-building clinical results, MDT's FDA-cleared LANAP® protocol removes the fear from gum disease treatment, offering a vastly less painful and less invasive regenerative treatment alternative to conventional surgery. Its PerioLase® MVP-7™ is a 6-watt free-running variable-pulsed Nd:YAG dental laser featuring 7 pulse durations giving it the power and versatility to perform a wide range of soft- and hard-tissue laser procedures. The PerioLase® MVP-7™ is also developed for the LAPIP™ protocol, for the treatment of ailing dental implants. The company's founding clinician, Robert H. Gregg, II, continues to operate the company with the vision: To create better clinical outcomes in periodontal disease patients—and to remain true to the guiding principle—"It's all about the patient."


To view the original version on PR Newswire, visit:

SOURCE Millennium Dental Technologies, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store